Toronto-Dominion Bank $2.75 billion notes offering
Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.75 billion aggregate principal amount of its 0.750% senior notes due 2023 and (ii) $1 billion…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Zhenro Properties Group $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 8.300% senior notes due 2023.
Zhenro Properties Group…
Aptiv $2.2 billion ordinary share and mandatory convertible preferred offerings
Davis Polk advised Aptiv PLC in connection with a $1.1 billion SEC-registered offering of 15,149,519 ordinary shares (which included 1,976,024 ordinary shares that the underwriters…
Mohawk Capital Finance €500 million notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Mohawk Capital Finance S.A. of fixed-rate notes due 2027. The notes are fully and unconditionally…
Westlake Chemical $300 million notes offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Westlake Chemical Corporation of $300 million aggregate principal amount of its 3.375%…
Bank of N.T. Butterfield & Son $100 million subordinated notes offering
Davis Polk advised the sole book-running manager in connection with an offering by The Bank of N.T. Butterfield & Son Limited of $100 million aggregate principal amount of its 5.250%…
BankUnited $300 million notes offering
Davis Polk advised the underwriters on an SEC-registered offering by BankUnited, Inc. of $300 million aggregate principal amount of 5.125% subordinated notes due 2030.BankUnited, Inc…
Hormel Foods $1 billion notes offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Hormel Foods Corporation of $1 billion aggregate…
Jazz Pharmaceuticals $850 million exchangeable senior notes offering
Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $850 million aggregate…
NetEase HK$20.9 billion secondary listing and IPO on HKEX
Davis Polk advised the underwriters in the secondary listing and initial public offering of NetEase, Inc. on the Hong Kong Stock Exchange. The gross proceeds from the global offering…